News | Radiation Therapy | September 19, 2017

Highlights include Halcyon IMRT platform and HyperArc high-definition radiotherapy system

Varian to Showcase Latest Radiation Therapy Technologies and Software at ASTRO 2017

September 19, 2017 — Varian Medical Systems announced it will be demonstrating its new Halcyon platform and HyperArc high-definition radiotherapy (HDRT) at the 2017 American Society for Radiation Oncology (ASTRO) Annual Meeting, Sept. 24-27 in San Diego. The company also will host its Users Meeting on Sept. 23 prior to the ASTRO meeting.

The Halcyon platform helps simplify and enhance virtually every aspect of image-guided volumetric intensity modulated radiotherapy (IMRT), while HyperArc HDRT is an advanced type of radiosurgery treatment.

In addition to Halcyon and HyperArc, Varian will showcase these solutions for simplifying and increasing access to advanced cancer care:

  • Eclipse 15.5 featuring treatment planning for HyperArc HDRT, RapidPlan knowledge-based planning, multicriteria optimization (MCO), plus fast optimization and dose calculation;
  • Iterative cone beam computed tomography (CBCT) on the TrueBeam platform, which produces exceptionally high quality images, according to the company, for better visualization of soft tissue structures;
  • ProBeam proton therapy, configurable as single- or multi-room solutions featuring gantries that rotate a full 360 degrees, RapidScan high-speed pencil-beam scanning for single-breath-hold lung SBPT and iterative CBCT for enhanced soft tissue resolution; and
  • Varian Marketplace, a digital marketplace for Varian and customer apps and software product extensions to solve real-world clinical and operational problems.

The Varian Users Meeting will provide attendees with new insights on the latest Varian technology. Topics include:

  • Early experience with the Halcyon system;
  • Multicriteria optimization and high-performance computing;
  • Using 360 Oncology care management to make multidisciplinary tumor boards smarter and more efficient;
  • Robust planning for proton therapy using the Eclipse system;
  • Multi-modality imaging in treatment planning, delivery and response assessment; and
  • First clinical impressions of HyperArc for treating brain metastases.

For more information: www.varian.com


Related Content

News | Radiation Therapy

May 16, 2024 — Today marks a significant milestone in cancer care with the introduction of bipartisan federal ...

Time May 16, 2024
arrow
News | Artificial Intelligence

May 14, 2024 — Elekta announced the launch of its latest linear accelerator (linac), Evo*, a CT-Linac with new high ...

Time May 14, 2024
arrow
News | Radiation Oncology

May 10, 2024 — Mariana Oncology, a fully integrated biotechnology company pioneering a new era of radiopharmaceutical ...

Time May 10, 2024
arrow
News | Radiation Oncology

May 10, 2024 — Insurance expansions under the Affordable Care Act (ACA) were linked with an increase in patients ...

Time May 10, 2024
arrow
News | Radiopharmaceuticals and Tracers

May 8, 2024 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of ...

Time May 08, 2024
arrow
News | Artificial Intelligence

May 2, 2024 — Radformation, Inc., a leader in automation solutions for cancer care, announced today that it has acquired ...

Time May 02, 2024
arrow
News | Prostate Cancer

May 2, 2024 — GT Medical Technologies, Inc. (GT MedTech), a medical device company with the mission of improving the ...

Time May 02, 2024
arrow
News | FDA

April 29, 2024 — The U.S. Food and Drug Administration (FDA) announced Elekta Instrument AB is recalling Disposable ...

Time April 29, 2024
arrow
News | Radiation Dose Management

April 25, 2024 — BIOTRONIK, a leading global medical technology company specializing in innovative cardiovascular and ...

Time April 25, 2024
arrow
News | Artificial Intelligence

March 28, 2024 — As artificial intelligence (AI) makes its way into cancer care – and into discussions between ...

Time March 28, 2024
arrow
Subscribe Now